The chemistry, pharmacokinetics, pharmacodynamics, clinical efficacy, dosage and ... the treatment of DVT. Tinzaparin may also be effective for unlabeled uses, such as prophylaxis of venous ...

Indications for anticoagulation include deep vein thrombosis (DVT), pulmonary ... If a patient is receiving thromboembolic prophylaxis via subcutaneous heparin, the drug should be discontinued ...

Patients with a history of atrial fibrillation, atrial flutter, deep vein thrombosis ... low dose, intermediate dose, or full dose. Low‐dose anticoagulation consisted of either low‐dose ...

Nine studies reporting on harms were identified. Harms included symptomatic deep venous thrombosis (4.13 (95% confidence interval 1.78 to 9.60) events per 1000 procedures), pulmonary embolism, ...

The manufacturers of Tinzaparin recommend 3500 units for prophylaxis of DVT in all general surgical patients. Orthopaedic patients are classified as high risk and should receive a weight based ...

This review included complications of access, the distal vessel (thrombosis, stenosis ... She was treated with low-dose heparin, sildenafil, and intraocular pressure-lowering eye drops. Fortunately, ...

Background: Consensus on the use of citrate vs.heparin for catheter locking remains elusive ... through appropriate locking is crucial for the effective prevention of thrombosis and CRBSI during the ...

and all demonstrated improvements in the use of VTE prophylaxis. Most studies evaluated change in provider behaviour, not patient outcome, and no study that evaluated outcomes demonstrated a reduction ...

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2, formerly 2019-nCoV) is a novel coronavirus that has rapidly disseminated worldwide, causing the coronavirus disease 2019 (COVID-19) pandemic ...

Two doses of tPA were given at doses of 0.6 mg/kg/hour followed by unfractionated heparin (UFH) infusion ... Administered treatment regimen for systemic thrombolysis includes a low dose alteplase ...